March 2020 ASHG: Why is public engagement with science important for both researchers and the public? Dr. Easter: As researchers, when we think about the need to engage with the public as research participants and partners in the process, we want people to understand what they’re being asked to do and why it matters. This empowers them to make decisions about participation, but also makes it... Read More
March 2020 In May 2019, ASHG leadership released the Society’s 2019-23 Strategic Plan, a document driving the next few years of Society priorities that outlines key avenues to advance the field and benefit members. To help achieve the Society’s vision that people everywhere realize the benefits of human genetics and genomics research, we understood that diversity and inclusion would need to be a priority. There is a growing recognition that when the genetic diversity of humans... Read More
March 2020 Human Genetics and Genomics Advances (HGG Advances), the newest member of the ASHG family, is a high-quality, society-led open access (OA) publishing option for the research community. Michael Bamshad, MD, will lead the journal as Editor-in Chief. The way that human genetics research is done is rapidly changing, characterized by more collaborative, networked,... Read More
You must be a member to access this page. Log in Become a Member If you believe you have a membership and are unable to log in contact membership@ashg.org Read More
Nascent Transcript Author: Anna Miller A recent decision by the pharmaceutical company Novartis to provide 100 free gene therapy treatments for spinal muscular atrophy (SMA), a debilitating yet rare genetic condition, to patients selected through a lottery program has sparked debate about the ethical implications. SMA is a rare autosomal recessive genetic disorder caused by... Read More